Invicro and Enigma Biomedical Group Sign a Collaboration Agreement

Toronto, Canada (August 20, 2018):  Enigma Biomedical Group (EBG) today announced a collaboration agreement with Invicro, a Konica Minolta Company and a leading provider of imaging services and software for research and drug development, to work together on multiple projects, initially focusing on the enhancement of Invicro’s AmyloidIQ and TauIQ platforms. EBG will be responsible for providing data from their affiliate companies; Cerveau Technologies, Inc. and Meilleur Technologies, Inc.; novel Tau tracer (MK-6240) and Amyloid tracer (NAV-4694); respectively.

(more…)

Dr. John E. Niederhuber Appointed Chairman of Konica Minolta’s Scientific Advisory Board

Aliso Viejo, CA (July 10, 2018):  Konica Minolta Precision Medicine Inc., a newly formed division of Konica Minolta focused on revolutionizing personalized patient care, announced today the appointment of Dr. John E. Niederhuber as the Chairman of their Scientific Advisory Board.

(more…)

Invicro Names Dr. Brian Avants as Senior Director of Machine Learning

BOSTON, MA, August 2, 2018 – Invicro LLC, a Konica Minolta company and a leading provider of imaging services and software for research and drug development, today announced the appointment of Brian Avants, Ph.D. as Senior Director of Machine Learning.

(more…)